Background The increased incidence of malignancies in patients with chronic renal failure
has been discussed since the mid-70s. On the other hand, the high frequency of chronic …

Background The overall risk of some cancers is increased in patients receiving regular
dialysis treatment due to chronic oxidative stress, a weakened immune system and …

Background One million people worldwide benefit from chronic dialysis, with an increased
rate in Western countries of 5% yearly. Owing to increased incidence of cancer in dialyzed …

Renal insufficiency has been shown to be highly prevalent in patients with cancer. This renal
insufficiency has been reported to be associated with reduced overall survival and …

Renal or hepatic impairment is a common comorbidity for patients with cancer either
because of the disease itself, toxicity of previous anticancer treatments, or because of other …

Background Elderly cancer patients commonly have renal function decline. This warrants
particular caution during the administration of renally excreted cancer drugs or those with …

The Renal Insufficiency and Anticancer Medications (IRMA) study is a French national,
observational study which demonstrated the high prevalence of abnormal renal function in a …

Background: Half of anticancer drugs are predominantly excreted in urine. Dosage
adjustment in renal insufficiency (RI) is, therefore, a crucial issue. Moreover, patients with …

Monitoring renal function in patients with solid tumors and hematologic malignancies is vital
to the safe administration of therapeutic agents. Renal impairment is frequent in elderly …

The use of novel targeted anticancer agents has led to overall improvement in the prognosis
of many patients affected by various malignancies, but has also been associated with an …